Cryo-Cell International, Inc.
AMEX: CCEL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange Arca
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- David Portnoy
- Employees
- 73
- Headquarters
- Oldsmar, United States
- IPO year
- 1994
- Market cap
- $26.4M
- Website
- https://www.cryo-cell.com
Loading CCEL…
Loading profile data…Frequently asked questions about CCEL
What does Cryo-Cell International, Inc. (CCEL) do?
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord...
Where does CCEL trade?
Cryo-Cell International, Inc. (CCEL) trades on the New York Stock Exchange Arca.
What sector is CCEL in?
Cryo-Cell International, Inc. (CCEL) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Cryo-Cell International, Inc.?
David Portnoy is the chief executive officer of Cryo-Cell International, Inc. (CCEL).
Where is Cryo-Cell International, Inc. headquartered?
Cryo-Cell International, Inc. is headquartered in United States.
Does CCEL pay a dividend?
Yes — Cryo-Cell International, Inc. (CCEL) paid a trailing twelve-month dividend of USD 0.60 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CCEL go public?
Cryo-Cell International, Inc. (CCEL) completed its initial public offering in 1994.